Acutaas Chemicals Ltd (NSE:ACUTAAS)
₹ 3,282 -15.9 (-0.48%) Market Cap: 268.73 Bil Enterprise Value: 266.41 Bil PE Ratio: 105.97 PB Ratio: 20.51 GF Score: 69/100

Q1 2027 Acutaas Chemicals Ltd Earnings Call Transcript

Jul 24, 2026 / 10:30AM GMT
Release Date Price: ₹3259.5 (-5.77%)

Key Points

Positve
  • Acutaas Chemicals Ltd (BOM:543349) reported a strong revenue growth of 59.1% year-over-year, reaching INR329.7 crores.
  • The company successfully completed the trial run of its battery chemicals plant and commenced commercial supply, indicating a strong demand and potential for rapid ramp-up.
  • Gross profit increased by 73% compared to the same period last year, with gross margins expanding by 466 basis points to 57.9%.
  • The company received the Responsible Care certification from the Indian Chemical Council, highlighting its commitment to safety, health, and environmental performance.
  • Acutaas Chemicals Ltd (BOM:543349) was certified as a Great Place to Work, reflecting a positive workplace culture and employee satisfaction.
Negative
  • The Specialty Chemicals segment saw a revenue decline of 10.6% year-over-year due to the phasing out of commodity chemicals.
  • Working capital days increased to 99 days from 91 days in the previous quarter, driven by higher inventory days.
  • The company faces geopolitical tensions in the Gulf, which could impact raw material availability and supply continuity.
  • Employee costs have been rising, with a projection of INR150 crores for the current year, potentially impacting profitability.
  • There is a transition gap expected between the phasing out of old products and the ramp-up of new specialty chemical products, which may affect short-term revenue.
Operator

Ladies and gentlemen, good day, and welcome to the Acutaas Chemicals Limited Q1 FY27 earnings conference call hosted by Nuvama Institutional Equities. (Operator Instructions)

I now hand the conference over to Mr. Archit Joshi from Nuvama Institutional Equities. Thank you, and over to you, sir.

Archit Joshi
Nuvama Institutional Equities - Analyst

Good evening, everyone, and thank you for joining us on Acutaas Chemicals' Q1 FY27 earnings conference call. Today, we have with us Acutaas Chemicals management represented by Mr. Naresh Patel, Chairman and Managing Director; Mr. Abhishek Patel, President, Strategy; and Mr. Bhavin Shah, Chief Financial Officer.

I would now like to invite Mr. Bhavin Shah to initiate proceedings. Over to you, sir, and thank you.

Bhavin Shah
Acutaas Chemicals Ltd - Chief Financial Officer

Thank you, Archit. Good evening, everyone. We are pleased to welcome you all to our earnings conference call to discuss Q1 FY27 financials. Please note that a copy of our disclosure is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot